News from mdedge.com
Your destination for news from mdedge.com. See how mdedge.com’s media bias impacts the breaking news stories of today.
The Ground News media bias check for mdedge.com is unknown. Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.
If you want to know if mdedge.com is credible or reliable, look no further. We rank mdedge.com as unknown factuality. Find out more about our methodology here.
Information about mdedge.comWhere is mdedge.com located?mdedge.com's Website
Media Bias Ratings
Does mdedge.com lean left or right?
Learn more about Media Bias Ratings.
Top mdedge.com News
FDA Mandates Changes to iPLEDGE Program for Isotretinoin
Isotretinoin manufacturers have 6 months to make five changes to existing iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) requirements for isotretinoin. MDedge NewsSee the Story
Even With Insurance, Cancer Out-of-Pocket Costs Can Be Punishing
Commercial health insurance does not necessarily protect cancer patients from potentially devastating out-of-pocket costs.See the Story
Canada Revenue Agency
How to Address Chemo-Related Amenorrhea in Early Breast Cancer to Help Improve Quality of Life
Persistent chemotherapy-related amenorrhea (CRA) after treatment for breast cancer was common and associated with worse long-term quality of life among premenopausal women.See the Story
Latest News Stories
Studies Support Early Use of Urate-Lowering Therapy, Warn of Peripheral Arterial Disease
A new analysis suggests that it may not be necessary to delay urate-lowering therapy in gout flares, and a study warns of the potential heightened risk for peripheral arterial disease in gout.See the Story